Loading...
What if Awe, Psychedelics and Trauma Work Share One Brain Switch?
Tamara Logica
15 May 2026
What if altered states share one repair switch?
What if the quiet after a trauma session, the vastness of standing under a night sky, and the intensity of a psychedelic journey were all pointing to the same hidden lever in the brain? Instead of three separate worlds, we may be looking at one shared mechanism: temporarily loosening the brain's self-story to open a narrow window for change.
Neuroscience increasingly places the Default Mode Network (DMN) at the center of this story – the network that supports autobiographical memory, self-referential thinking, and our ongoing narrative about who we are in relation to others (Buckner et al., 2008; Raichle, 2015). When trauma, psychedelics, or awe shake this network, the system can become more flexible – or dangerously unmoored – depending on how safe and supported the person is (van Elk et al., 2019; Vollenweider & Kometer, 2010; Williams, 2024).
The DMN under trauma, psychedelics and awe
Trauma exposure is linked to reduced DMN connectivity, increased rigidity between networks, and a disrupted sense of narrative self, sometimes described as a traumatized resting state with heightened salience and reduced executive control (Lanius et al., 2015; Williams, 2024). Effective trauma therapies appear to partially restore DMN coherence and narrative integration, supporting a more flexible, less threat-dominated self-story (Frewen & Lanius, 2015).
Classic psychedelics such as psilocybin reliably decrease DMN integrity, increase communication between networks, and correlate with ego-dissolution experiences – a temporary softening of the usual sense of self (Carhart-Harris et al., 2012; Madsen et al., 2019). Clinical and ethical reviews emphasize that these same mechanisms can be healing or destabilizing depending on preparation, screening and support, especially in people with trauma histories or psychosis vulnerability (Letheby & Gerrans, 2017; Yaden et al., 2020).
Awe studies using functional MRI show reduced engagement of core DMN hubs and a shift away from self-focused rumination toward immersion in the environment, often with a felt sense of a smaller, more connected self (van Elk et al., 2019; Shiota et al., 2007). In everyday contexts, awe is associated with increased well-being, prosociality and a broadened sense of time, especially when experienced in safe, supportive settings such as nature or art (Keltner & Haidt, 2003; Rudd et al., 2012).
Shared mechanism: loosening rigid self-models
Taken together, the evidence suggests a common thread: trauma reprocessing, psychedelic states and awe all reduce rigid DMN-driven self-modeling and open a temporary window in which new meanings and sensations can be integrated (Lanius et al., 2015; Carhart-Harris & Friston, 2019; van Elk et al., 2019). The crucial difference is not the DMN disruption itself, but whether the person has enough internal regulation and external safety to use that window constructively rather than being overwhelmed.
Side-by-side: three paths to DMN de-centering
The table below distills the shared mechanisms and safety requirements of trauma reprocessing, psychedelics and awe into a compact, clinically usable overview.
| Phenomenon | Shared neural mechanisms (evidence) | Role of environmental safety (evidence) |
|---|---|---|
| Trauma reprocessing (e.g. EMDR, trauma-focused CBT, parts work) | Trauma is associated with reduced DMN connectivity, increased salience network dominance and narrative fragmentation; effective therapies partially restore DMN integration and autobiographical coherence (Lanius et al., 2015; Williams, 2024). | Without titration and a sense of safety, exposure can re-activate avoidance, hypervigilance and dissociation; secure therapeutic containment is a precondition for successful reprocessing (Frewen & Lanius, 2015). |
| Psychedelics (e.g. psilocybin-assisted therapy) | Psilocybin reduces DMN integrity, increases cross-network communication and correlates with ego-dissolution, enhancing neural entropy and cognitive flexibility (Carhart-Harris et al., 2012; Madsen et al., 2019). | Unsafe set and setting, poor screening or lack of support increase risk of panic, psychosis-like reactions and destabilization; clinical guidelines stress rigorous preparation, monitoring and integration (Yaden et al., 2020). |
| Awe (e.g. vast nature, music, spiritual experiences) | Awe-eliciting stimuli reduce DMN activity and self-referential thought, shifting attention outward and enhancing immersion in the environment (van Elk et al., 2019). | In safe contexts, awe can buffer stress and enhance well-being; in highly traumatized systems, the same self-diminishing experience can be interpreted as threat, tipping into overwhelm or panic if internal safety is low (Keltner & Haidt, 2003; Trauma Aware America, 2024). |
A compact readout for practice
- Common thread: all three states temporarily loosen rigid self-models linked to DMN activity, reopening a window for narrative or sensory re-integration when safety and regulation are present (Lanius et al., 2015; Carhart-Harris & Friston, 2019).
- Distinct safety thresholds: trauma work and psychedelics demand highly structured containment; awe can be beneficial in naturally safe contexts but is not, by itself, a therapy (Yaden et al., 2020; van Elk et al., 2019).
Clinical safety boundary: when the switch becomes a trap
Across psychedelic trials and trauma treatments, the safest conclusion is that the real therapeutic ingredient is not DMN disruption alone, but DMN disruption inside a scaffold of psychological safety, integration capacity and co-regulation (Carhart-Harris et al., 2018; Yaden et al., 2020). In psychedelic work this appears as the emphasis on set and setting, careful screening and structured integration sessions; in trauma care it appears as phased, titrated exposure and strong therapeutic alliance (Frewen & Lanius, 2015).
Similarly, in neurodevelopmental conditions such as autism, prolonged shutdown or catatonia-like states are best treated as potential warning signs of metabolic and regulatory overload, not automatically as restorative refractory periods (Werneke et al., 2016). The same drop in DMN-driven self-processing can either mark a healing pause or a slide into collapse, depending on whether the environment is actively supporting recovery.
| State | Safety and integration needed | Risk when safety is missing |
|---|---|---|
| Trauma reprocessing session | Clear framework, titration, strong alliance, grounding skills, post-session integration. | Re-traumatization, renewed avoidance, dissociation, drop-out from therapy. |
| Psychedelic-assisted session | Screening, stable setting, trained guides, medical oversight, integration over weeks. | Panic, psychosis-like decompensation, destabilization of pre-existing vulnerabilities. |
| Spontaneous awe experience | Physically safe context, emotional support available, time to reflect. | Ontological shock, threat-like interpretation, amplification of existential anxiety. |
What if the real universal law is this: brief DMN de-centering may open a window for repair, but healing only writes to the system when regulation, safety and post-state integration are in place.
A refined, falsifiable hypothesis
Instead of assuming that turning down the DMN is automatically curative, the more defensible, falsifiable hypothesis looks like this:
- Brief reductions in self-referential processing appear in awe, psychedelic states and sometimes in shutdown-like states in autism and trauma (Carhart-Harris et al., 2012; van Elk et al., 2019).
- Therapeutic benefit emerges only when the person has sufficient safety, support and integration capacity to metabolize what surfaces afterward.
- When these conditions are absent, the same state shift increases risk of panic, re-traumatization or prolonged dysfunction.